Avaris AB
Records under this name other than patents Avaris AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 8 of 8 · Back to Avaris AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,585,914 | Expanded NK cells Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,067,964 | Complex and method for enhancing nuclear delivery Formerly held Lapsed on the fee record Ended Jun 30, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 30, 2019 | From the USPTO record |
| US 6,720,310 | Transfer method for specific cellular localization of nucleic acids Lapsed on the fee record Ended Apr 13, 2016 · From the USPTO record | Lapsed on the fee record | Ended Apr 13, 2016 | From the USPTO record |
| US 7,829,686 | Nucleic acid encoding a subunit of Na+,K+-ATPase Lapsed on the fee record Ended Nov 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 9, 2014 | From the USPTO record |
| US 7,824,853 | Complex comprising at least two biospecific elements separated by a nucleic acid linker e.g. for identification of drug delivery candidates combinatorial library of such complexes Lapsed on the fee record Ended Nov 2, 2014 · From the USPTO record | Lapsed on the fee record | Ended Nov 2, 2014 | From the USPTO record |
| US 7,645,603 | Cells having cardiac glycoside resistance Lapsed on the fee record Ended Jan 12, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 12, 2014 | From the USPTO record |
| US 6,309,874 | Selection marker Lapsed on the fee record Ended Oct 30, 2013 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2013 | From the USPTO record |
| US 6,869,796 | Method of introducing organic molecules into target cells Lapsed on the fee record Ended Mar 22, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2013 | From the USPTO record |